Search

Your search keyword '"Tan AC"' showing total 524 results

Search Constraints

Start Over You searched for: Author "Tan AC" Remove constraint Author: "Tan AC"
524 results on '"Tan AC"'

Search Results

1. Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

2. Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma

3. Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases

5. Health and support service needs of individuals with disability from culturally and linguistically diverse backgrounds: a scoping review protocol.

6. International representation of authors, editors and research in neurology journals.

7. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

9. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study

10. Is retrospective assessment of health-related quality of life valid?

11. Molecular and clonal evolution in recurrent metastatic gliosarcoma

14. Prevalence of Chronic Hepatitis B and C in Malaysia- results from a community-based screening campaign

15. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

16. Why unidimensional pain measurement prevails in the pediatric acute pain context and what multidimensional self-report methods can offer

17. Chronic Widespread Pain and Fibromyalgia Syndrome: Life-Course Risk Markers in Young People

18. Data quality audit of a clinical quality registry: A generic framework and case study of the Australian and New Zealand Hip Fracture Registry

21. The Transient Collaborative Network Approach: Theoretical and Practical Considerations

22. Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models

24. Intestinal barrier dysfunction in a randomised placebo-controlled trial of probiotic prophylaxis in acute pancreatitis

29. Novel agents in the treatment of metastatic colorectal cancer.

30. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

31. Data sharing policies across health research globally: Cross-sectional meta-research study.

32. The classification of melanocytic gene signatures.

33. Fingerprinting Tertiary Structure in Complex RNAs Using Single-Molecule Correlated Chemical Probing.

34. The impact of the COVID-19 pandemic on dyslipidemia in peritoneal dialysis patients.

35. The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.

37. The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer.

38. Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC.

39. Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response.

40. Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations.

41. [Relationship between serum 1, 5-anhydroglucitol level and insulin resistance, microvascular complications in type 2 diabetes mellitus].

42. SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte Lineage.

43. Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.

44. Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials.

45. The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population.

46. Soluble immune-checkpoint factors: a potential immunotherapy biomarker.

47. An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level.

48. A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset.

49. Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

50. Immune landscape in molecular subtypes of human papillomavirus-negative head and neck cancer.

Catalog

Books, media, physical & digital resources